Literature DB >> 12002416

Biochemical parameters of endothelial dysfunction in cardiological syndrome X.

W Kolasińska-Kloch1, W Leśniak, B Kieć-Wilk, M Malczewska-Malec.   

Abstract

UNLABELLED: The endothelial dysfunction in cardiological syndrome X has been studied mainly by invasive methods and by measuring vasoactive mediator (nitric oxide (NO), endothelin-1) levels. Other parameters evaluating this dysfunction (defined as an imbalance between vascular relaxing and contracting factors, between procoagulant and anticoagulant or growth-inhibiting and growth-promoting substances) have not been used.
METHODS: Twenty-five non-diabetic patients (16 men, 9 women) with cardiological syndrome X and 10 healthy volunteers (5 men, 5 women) were examined. Biochemical parameters: ET-1, the end products of nitric oxide metabolism (NOx), VEGF, vWF, betaTG, tPA, PAI-1 were measured before and during an ECG exercise tolerance test. The blood concentrations of testosterone and estradiol in men and LH, FSH and estradiol in women were tested.
RESULTS: A significantly lower basal concentration of NOx (p=0.01), lower basal NOx/ET-1 ratio (p<0.05) and higher levels of VEGF (p<0.05) were observed in patients with cardiological syndrome X. The male patients also had higher concentrations of estradiol (p<0.05). A significant decrease in tPA concentration and increase in betaTG was noticed during exercise, but with no differences between the study groups.
CONCLUSIONS: Endothelial dysfunction in cardiological syndrome X manifests mainly in the regulation of vessel wall tonus. which was revealed by the decrease of NOx level and NOx/ET-1 ratio. VEGF elevation in syndrome X may result from chronic tissue ischaemia due to endothelial dysfunction. Exercise augments the prothrombotic activity of the blood, since a significant elevation in betaTG and decrease in tPA were observed after exercise.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12002416     DOI: 10.1080/003655102753517145

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  8 in total

1.  Association between microvascular angina and erectile dsyfunction.

Authors:  S Demirkol; S Balta; U Kucuk; T Celik; Z Arslan; H Olgun Kucuk; M Unlu; U Cagdas Yuksel; S Samedli; M Yokusoglu; A Iyisoy; H Kursaklioglu
Journal:  Int J Impot Res       Date:  2013-12-19       Impact factor: 2.896

Review 2.  Gender and microvascular angina.

Authors:  Lynn Nugent; Puja K Mehta; C Noel Bairey Merz
Journal:  J Thromb Thrombolysis       Date:  2011-01       Impact factor: 2.300

Review 3.  Cardiac syndrome X in women: the role of oestrogen deficiency.

Authors:  J C Kaski
Journal:  Heart       Date:  2006-05       Impact factor: 5.994

4.  The association of brachial flow-mediated dilation and high-sensitivity C-reactive protein levels with Duke treadmill score in patients with suspected microvascular angina.

Authors:  Chufan Luo; Yi Li; Donghong Liu; Chengheng Hu; Zhimin Du
Journal:  Exp Clin Cardiol       Date:  2012

5.  Prothrombotic profile in patients with vasospastic or non vasospastic angina and non significant coronary stenosis.

Authors:  Jaume Figueras; Jasone Monasterio; Enric Domingo; Beatriz Meneses; Elsa Nieto; Josefa Cortadellas; David Garcia-Dorado
Journal:  Thromb J       Date:  2011-05-27

6.  Triglyceride to high-density lipoprotein cholesterol ratio as a predictor of long-term mortality in patients with coronary artery disease after undergoing percutaneous coronary intervention: a retrospective cohort study.

Authors:  Xin-Ya Dai; Ying-Ying Zheng; Jun-Nan Tang; Xu-Ming Yang; Qian-Qian Guo; Jian-Chao Zhang; Meng-Die Cheng; Feng-Hua Song; Zhi-Yu Liu; Kai Wang; Li-Zhu Jiang; Lei Fan; Xiao-Ting Yue; Yan Bai; Zeng-Lei Zhang; Ru-Jie Zheng; Jin-Ying Zhang
Journal:  Lipids Health Dis       Date:  2019-12-04       Impact factor: 3.876

7.  Serum ADMA concentration-- an independent factor determining FMD impairment in cardiac syndrome X.

Authors:  Maciej Haberka; Katarzyna Mizia-Stec; Zbigniew Gasior; Magdalena Mizia; Joanna Janowska; Michał Holecki; Barbara Zahorska-Markiewicz
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

8.  The effect of nicorandil in patients with cardiac syndrome X: A meta-analysis of randomized controlled trials.

Authors:  Qiulei Jia; Shuqing Shi; Guozhen Yuan; Jingjing Shi; Shuai Shi; Yi Wei; Yuanhui Hu
Journal:  Medicine (Baltimore)       Date:  2020-09-11       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.